Researchers study Chagas disease—aim to prevent transmission

Preventing transmission of Chagas disease
Credit: Thinkstock

EU funding has supported a major initiative designed to promote research collaboration to support control programmes for Chagas disease in central and southern America.

Chagas disease is caused by a protozoan and is contracted mainly in central and southern America. Spread primarily by blood-sucking insect vectors, most commonly species of the Triatoma and Rhodnius genera, the disease can produce life-threatening symptoms in around a third of chronically infected individuals.

One feature of the life-cycle of the insect vector is that deforestation encourages the search for new food sources, in this case , and a cycle may develop. The 'American trypanosomiasis update' (ATU) project therefore focused on control activities against the triatomine bug vector.

ATU researchers aimed to investigate the involved in adaptation from a sylvatic (forest) to a domestic environment and to set up workshops to disseminate the collated information. Three regional initiatives were set up in southern cone countries, the Andean Pact and central America.

In field studies, samples of insects were collected and analysed before comparing with data from before the start of the bug control campaign. The species under study depended on the region as, for example, in the southern cone countries. In this region, T. infestans has been eliminated so the study also focused on other vector species. In the Andean countries, both domestic and sylvatic species came under investigation.

ATU collected new information on the biology and potential vectors for Chagas disease as well as new tools for the control and surveillance of the vector bug. Exchange of information among experts on the disease, professionals involved in control programmes, and scientists proved very fruitful. Abstracts from contributions at the workshops can be viewed online and in a publication distributed to all control programmes, Pan American Health Organization (PAHO) and universities involved in Chagas disease research.

The ATU has promoted a major initiative for information exchange and the standardisation of criteria for control interventions to eliminate the of Chagas disease. As Chagas disease affects as many as 8 to 10 million people in Latin American countries, this is a very important issue for healthcare authorities.

add to favorites email to friend print save as pdf

Related Stories

FDA approves new test for Chagas disease

Nov 26, 2011

The Food and Drug Administration has approved Abbott Laboratories' ESA test for Chagas disease, which could be a useful tool in protecting the nation's blood supply from contamination.

Dogs may help collar Chagas disease

Jul 12, 2010

Chagas disease, for example, is caused by a parasite that roams with only limited control among the rural poor in Latin America. The main vector for the parasite Trypanosoma cruzi is the triatomine insect, or "kissing bug," ...

Recommended for you

Recorded Ebola deaths top 7,000

10 hours ago

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

14 hours ago

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

Dec 19, 2014

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

Dec 19, 2014

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.